logo

Exhibiting at VIV Asia 2025

3-4340
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Product Categories:

Pharmaceutical Ingredients, Veterinary Drug Materials

Products:

Macrolides: Azithromycin, Clarithromycin, Roxithromycin

Quinolones: Ciprofloxacin Hydrochloride, Ciprofloxacin Lactate, Ciprofloxacin, Ciprofloxacin Mesylate, Moxifloxacin

Veterinary APIs: Ciprofloxacin Hydrochloride, Ciprofloxacin, Enrofloxacin, Marbofloxacin, Diclazuril

Special APIs: Azelnidipine, Fudosten, Mitiglinide, Desoxyfluridine, Solifenacin, Vildagliptin

Key Pharmaceutical Intermediates: Dihydrohomoerythromycin, Erythromycin Oxime, Cyclopropanecarboxylic Acid

Product Gallery:

Zhejiang Guobang Pharmaceutical Co., Ltd., headquartered in Shaoxing, China, is a high-tech enterprise specializing in the research, development, manufacturing, and distribution of high-quality Active Pharmaceutical Ingredients (APIs), veterinary APIs, pharmaceutical intermediates, and specialty chemicals. The company is recognized for its technological advancements and adherence to international quality standards.

Core Business and Product Offerings

Zhejiang Guobang Pharmaceutical Co., Ltd. focuses on the production of macrolides, quinolones, special APIs, veterinary APIs, and key pharmaceutical intermediates. The company's extensive product portfolio caters to the pharmaceutical, veterinary, and biotechnology industries worldwide.

Product Categories

  1. Macrolides

    • Azithromycin: A widely used antibiotic for treating respiratory, skin, and sexually transmitted infections.
    • Clarithromycin: Effective in treating various bacterial infections, especially those affecting the respiratory tract.
    • Roxithromycin: Commonly used for treating respiratory tract, urinary, and soft tissue infections.
  2. Quinolones

    • Ciprofloxacin Hydrochloride: A broad-spectrum antibiotic used to treat bacterial infections in humans and animals.
    • Ciprofloxacin Lactate: Applied in veterinary medicine for the treatment of bacterial infections.
    • Ciprofloxacin: Effective against various Gram-positive and Gram-negative bacterial infections.
    • Ciprofloxacin Mesylate: A derivative of ciprofloxacin with enhanced efficacy.
    • Moxifloxacin: Used for treating respiratory infections, particularly pneumonia and bronchitis.
  3. Special APIs

    • Azelnidipine: A calcium channel blocker used for hypertension treatment.
    • Fudosten: Applied in pharmaceutical formulations for specific therapeutic purposes.
    • Mitiglinide: A short-acting insulin secretagogue used for the management of Type 2 diabetes.
    • Desoxyfluridine: An antineoplastic agent used in cancer treatment.
    • Solifenacin: A muscarinic receptor antagonist used for treating overactive bladder.
    • Vildagliptin: An oral anti-diabetic agent used for improving glycemic control.
  4. Veterinary APIs

    • Ciprofloxacin Hydrochloride: Widely used in veterinary medicine for its antibacterial properties.
    • Enrofloxacin: Commonly used in livestock and poultry for the treatment of bacterial infections.
    • Marbofloxacin: Effective against a broad range of pathogens affecting animals.
    • Diclazuril: An anticoccidial drug used for preventing and treating coccidiosis in poultry.
    • Ciprofloxacin: A versatile antibiotic applied in both human and veterinary medicine.
  5. Key Pharmaceutical Intermediates

    • Dihydrohomoerythromycin: An intermediate used in the synthesis of macrolide antibiotics.
    • Erythromycin Oxime: A crucial intermediate in the production of various macrolide antibiotics.
    • Cyclopropanecarboxylic Acid: Used in the synthesis of pharmaceutical compounds.

Specialization and Unique Selling Proposition (USP)

Zhejiang Guobang Pharmaceutical Co., Ltd. has established itself as a leading manufacturer of macrolides, quinolones, and special APIs. The company's unique selling propositions include:

  • Comprehensive Product Range: Providing high-quality APIs and intermediates for both human and veterinary pharmaceuticals.
  • Integrated Manufacturing Facilities: State-of-the-art production lines equipped with advanced technology ensuring product consistency and purity.
  • Research & Development: A dedicated R&D team continuously working on developing new formulations and improving manufacturing efficiency.
  • Global Regulatory Compliance: Adherence to international standards including GMP, ISO9001, and other relevant certifications.
  • Strong Market Presence: Significant market share in China, Southeast Asia, Europe, and North America.

Financial Performance and Market Reach

Zhejiang Guobang Pharmaceutical Co., Ltd. is a well-established player in the global pharmaceutical industry, particularly in the manufacturing of macrolides and quinolones. The company's revenue growth is largely driven by its extensive export operations targeting regions such as Southeast Asia, Europe, and North America.

Its strategic focus on developing high-quality APIs for both human and veterinary use has contributed to consistent revenue generation. Additionally, the company's investment in research and technological advancements continues to expand its market reach.

International Shipments Data

The company's products are widely exported to markets with high demand for antibiotics, special APIs, and veterinary medicines. Major shipment destinations include:

  • Southeast Asia: High demand for veterinary APIs such as Enrofloxacin and Ciprofloxacin.
  • Europe: Increasing export of macrolides and quinolones for human pharmaceuticals.
  • North America: Continuous supply of APIs for human and veterinary pharmaceuticals.

Certifications and Compliance Records

Zhejiang Guobang Pharmaceutical Co., Ltd. adheres to strict quality standards and regulatory requirements. Its certifications include:

  • GMP Certification: Compliance with Good Manufacturing Practices ensuring product quality and safety.
  • ISO9001: Quality Management System Certification.
  • FDA Approval: Several of its APIs meet the stringent requirements of the United States Food and Drug Administration.

These certifications reflect the company's commitment to maintaining high standards of quality, safety, and reliability.

Capabilities

The company's manufacturing facilities are equipped with cutting-edge technology capable of producing large quantities of APIs and intermediates with precision and consistency. Its research and development capabilities ensure the continuous improvement of production processes and product formulations.

The company's strong supply chain management ensures timely delivery of products to various markets worldwide, further strengthening its reputation as a reliable supplier.

Major Achievements

  • Recognized as a top manufacturer of macrolides and quinolones in China.
  • Successful expansion into international markets including Southeast Asia, Europe, and North America.
  • Development of new APIs and intermediates catering to evolving market demands.

Customer Testimonials

The company's products are highly regarded for their quality, efficacy, and consistency. Customers have highlighted the company's ability to provide reliable solutions that meet stringent regulatory standards.

Zhejiang Guobang Pharmaceutical Co., Ltd. continues to strengthen its position in the global pharmaceutical industry by investing in research, expanding its product portfolio, and maintaining high standards of quality and customer satisfaction.